The 2003 San Diego Bio-Pharma Award

Recipient: Fang Fang, M.D., Ph.D., Vice President and Chief Scientific Officer, Perlan Therapeutics Talk Title: ColdSol, a solution for the common cold and a personal journey of product invention

 

Dr. Fang is the inventor of Perlan’s flagship product, ColdSol™, a nasal spray for prevention and treatment of the common cold. In 2002, ColdSol™ won the Connect Most Innovative Product Award in biotech R&D category. She was also elected to be the 10 San Diego innovators of the next generation technology leadership, featured in the first issue of “T-Sector” technology magazine of 2003. Dr. Fang served as the Scientific & Medical Director for Perlan Therapeutics, Inc. since its incorporation in 1997 and was promoted to the current position in 2001. She was a member of Perlan’s board of directors since 2001. Dr. Fang obtained her M.D. degree from Peking Union Medical College with the highest honor and was awarded the Union Friends Foundation Award. She obtained her Ph.D. degree in molecular biology from the University of California, San Diego (UCSD) and was awarded the Kamen Prize for Best Thesis. Dr. Fang did post-doctoral training with Dr. Erkki Ruoslahti, then CEO of the Burnham Institute at San Diego. She then finished residency in anatomic pathology at the Massachusetts General Hospital, Harvard Medical School, where she initiated and organized clinical studies on novel diagnostic procedures including a telomerase assay for early cancer diagnosis. Before joining Perlan, she was a Howard Hughes Physician Scientist Fellow working at the Salk Institute. She also consulted for Ancile Pharmaceuticals on both scientific and medical issues. She has published in several prestigious scientific journals including CELL and SCIENCE. She is the principle investigator of three Phase I and Phase II SBIR grants from NIH and the 2002 CalTIP award from California state government.